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of luteinizing hormone (LH) required for normal follicular development is still unknown, it has been demonstrated that The Howard and Georgeanna Jones Institute for Reproductive only a minimal amount of LH is required for ovarian steroidoMedicine, 601 Colley Avenue, Norfolk, VA 23507, USA genesis and normal follicular development (Hillier, 1990;  1 To whom correspondence should be addressed Bergh et al., 1993) . Furthermore, elevated LH concentrations during the late follicular phase and peri-ovulatory period have The aim of this study was to compare the efficacy of pure detrimental effects on oocyte quality, fertilization, cleavage, follicle stimulating hormone (FSH) with that of FSH/human embryo quality and pregnancy rates (Stanger and Yovich, menopausal gonadotrophin (HMG) combination in down-1985; Howles et al., 1987) . It also increases the miscarriage regulated cycles. A total of 357 patients was evaluated rates (Homburg et al., 1988; Regan et al., 1990) . Howles et al. retrospectively . Sixty percent of patients in the FSH group (1987) found that pregnancy rates were lower in patients with and 55% in the FSH/HMG group were new; the others were elevated LH concentrations 2 days prior to human chorionic repeat patients. Ovulation was suppressed with leuprolide gonadotrophin (HCG) administration. HMG increases LH and acetate in all patients, followed by either FSH (n ϭ 218) follicular fluid testosterone concentrations that may impair or FSH/HMG (n ⍧ 119). There was no difference in oocyte quality and implantation (McNatty et al., 1979 ; Polan patients' age, infertility factors, number of ampoules used, et al., 1986) , whereas pure FSH results in a decrease in LH length of stimulation, oestradiol levels on day of human concentrations (Kamrava et al., 1982; Venturoli et al., 1984 ; chorionic gonadotrophin (HCG) administration, number Anderson et al., 1989) . It has been suggested that higher LH of oocytes recovered or the number of embryos transferred.
concentrations may prematurely allow resumption of meiotic Also, nuclear maturity at aspiration and fertilization rates maturation (Jacobs et al., 1987) . Premature luteinization can were not different between the two groups. FSH stimulation be observed despite routine use of gonadotrophin-releasing resulted in a significantly higher percentage of mature hormone analogues (GnRHa) for pituitary desensitization and oocytes that showed the typical 'mature' morphological this may be due to the HCG content of HMG. Therefore it characteristics (P < 0.0001). The clinical pregnancy rates has been recommended that exogenous LH should be used only per transfer were 40 and 28% in patients stimulated with for patients with hypogonadotrophic hypogonadism (Shoham pure FSH and FSH/HMG respectively (P < 0.05). ) significantly higher number of immature oocytes matured Although several previous prospective randomized studies in vitro in the FSH/HMG group (P ⍧ 0.001) suggests a demonstrated that there was no difference between pure FSH possible effect on in-vitro maturation, due to luteinizing and HMG regarding pregnancy rates (Polan et al., 1986 ; hormone present in HMG. The difference in mature oocyte Sccocia et al., 1987; Lavy et al., 1988; Edelstein et al., 1990 ; quality may be an important determinant in the higher Tanbo et al., 1990) , a recent meta-analysis revealed that pure pregnancy rates for the FSH-stimulated patients.
FSH increased the pregnancy rates by 50% (Daya, 1995 Shoham et al., 1991) .
on the availability of medications and the patients' prior stimulation Although pure FSH was originally developed for the treatexperience. No bias was applied in choosing patients for a particular ment of patients with polycystic ovarian syndrome, it is now protocol. All patients were suppressed with leuprolide acetate (LA) widely used in the treatment of almost all patients applying (Lupron; TAP Pharmaceuticals, Abbott Park, IL, USA) using the long protocol. Lupron was commenced in the mid-luteal phase of the for assisted reproduction. Pure FSH also can be administered preceding cycle at the dose of 1 mg/day and reduced to 0.5 mg/day at the two pronuclear (2-PN) stage using 1,2-propanodiol as cryoproa P Ͻ 0.0001 (expanded cumulus and corona, round even shape, light colour tectant. Luteal phase was supported using progesterone 50 mg i.m.
of the ooplasm, and presence of first polar body at aspiration). b Germinal vesicle.
daily beginning on the day of embryo transfer. All oocytes were c P ϭ 0.001.
assessed at aspiration for corona/oocyte morphology (corona density, ooplasm colour, oocyte shape and nuclear morphology) and fertilization outcome. Oocytes were classified into mature (metaphase II, or repeat patients (data not shown). Similarly, both groups were metaphase I), immature (presence of a germinal vesicle), or atretic.
comparable for total oocytes aspirated, mature oocytes, number
Typical desired morphology for mature oocytes was defined as of ampoules used and oestradiol concentrations at the day of metaphase II oocytes (presence of first polar body), with expanded HCG (Table II) . Cancellation rates and cycles with freezing cumulus and corona, round even shape, and light, uniform coloration were 6.4 and 48%, 7.5 and 41% in the pure FSH and FSH/ of the ooplasm. Oocyte identification and classification were per-HMG groups respectively, and the difference was found to be formed by the two senior embryologists (J.M. and D.W.) who were insignificant. Also, the mean number of embryos frozen was unaware of the type of stimulation protocol used at the time. All comparable between two groups (6.5 Ϯ 5.1 in the FSH group patients underwent an initial serum test for β-HCG 12-14 days after embryo transfer. Clinical pregnancies were defined as the presence and 7.9 Ϯ 5.7 in the FSH/HMG group). Although there was of a gestational sac by ultrasound at 6-7 weeks gestation. The no difference in the number of mature oocytes between the implantation rate was defined as the number of gestational sacs seen two groups (Table III) , mature oocytes with typical desired by first trimester ultrasound divided by the total number of embryos morphology were significantly higher in the FSH-only group transferred.
(P Ͻ 0.0001). In contrast, the percentage of immature oocytes matured in vitro was significantly higher in the combination
Statistical analysis
protocol (P ϭ 0.001; Table III) . Fertilization rates, the number All data were compared using Fisher exact test and P-values Ͻ 0.05 of 2-PN from mature oocytes and immature oocytes, the were considered significant.
number of 3-PN from mature oocytes, and miscarriage rates (Table IV) were not different between two stimulation protoResults cols. Although clinical pregnancy rates per attempt and retrieval, and delivery rate appeared higher in the FSH alone A total of 337 patient cycles was studied: in 119, the FSH/ HMG combination and in 218, pure FSH were used. There group, the difference was not significant; however, clinical pregnancy rate per transfer was significantly higher in FSH was no difference between the two groups in mean age of patients, number of new and repeat patients and aetiology of alone group (40 versus 28%, P Ͻ 0.05). The implantation rate also appeared higher in the FSH group (11.6 versus 9.3%) infertility (Table I ). There were no significant differences in the aetiology of infertility within each group of new or (Table IV) but the difference was not statistically significant. was found to be higher in the Metrodin group, but the difference Wikland et al. (1995) . Although pregnancy rates per attempt and retrieval were higher in the Metrodin group, the difference Results are percentages; actual figures in parentheses. a P Ͻ 0.05.
was not significant. Also no difference was observed in number of oocytes retrieved, number of mature and immature oocytes, fertilization rates, miscarriage and ongoing pregnancy rates, The incidence of severe ovarian hyperstimulation was similar but the number of mature oocytes with typical morphology in the FSH (n ϭ 3) and the FSH/HMG (n ϭ 2) groups.
was significantly higher in the Metrodin group. Because there was no difference in other parameters, the higher pregnancy Discussion rates may be due to a higher rate of mature oocytes with desired morphological appearance in the pure FSH group. It The first clinical pregnancy using pure FSH was reported by Flamigni et al. (1985) in a woman with polycystic ovarian has been reported that the oocytes from patients with high LH were darker in colour but did not show signs of degeneration disease and the first pregnancy using GnRHa suppression and Metrodin was achieved in 1985 (Shaw et al., 1985) . (Stanger and Yovich, 1985) . Similarly, Imthurn et al. (1996) demonstrated that highly purified FSH resulted in a higher Several prospective randomized studies demonstrated that there was no difference between Metrodin and HMG regarding proportion of mature oocytes and fewer oocytes with dark cytoplasm than HMG. The higher percentage of immature fertilization and pregnancy rates (Polan et al., 1986; Scoccia et al., 1987; Lavy et al., 1988; Edelstein et al., 1990 ; Tanbo oocytes that mature in vitro suggests that the LH present in the combination protocol may influence the in-vitro maturaet al., 1990) . However, most of these studies were small and included Ͻ20 cycles in each group. Also, in some other tion process.
Although it is generally reported that ovulation induction recently published and larger studies (Howles et al., 1994; Hull et al., 1995) comparable results were obtained between using FSH alone results in lower oestradiol concentrations on the day of HCG (Edelstein et al., 1990; Fried et al., 1996) , FSH and HMG. Howles et al. (1994) , in a multicentre European study, found that there was no difference regarding oocytes this has no practical value, because it has been demonstrated that oestradiol concentration was not a good indicator for recovered, cleavage and pregnancy rates between s.c. highly purified FSH and HMG and reported results with HMG. Also, pregnancy potential (Howles et al., 1994) . In the present study no difference was observed in oestradiol concentrations on the Hull et al. (1995) , in a study including 2204 cycles with use of FSH alone, found that the overall results were comparable day of HCG between the two groups. It should be emphasized that our study used pure urinary with HMG, but both of these studies used historic data as the control groups. Similarly, Check et al. (1995) , in a prospective FSH. The results may be different with newer preparations such as highly purified (HP) urinary FSH or recombinant FSH. randomized study, found comparable results between HMG and FSH. Devroey et al. (1995) in a randomized study Westergaard et al. (1996) , in a prospective randomized trial, reported a lower fertilization rate in down-regulated HP-FSH including 158 patients compared Normegon (75 IU FSH and 25 IU LH) and Metrodin and found no difference regarding patients and lower oestradiol concentrations on cycle day 8 compared to HMG-stimulated patients. However, the duration the number of oocytes recovered, fertilization, embryo transfer and pregnancy rates.
of stimulation, mean number of ampoules used, and clinical pregnancy rate were similar in the two groups. Fleming et al. Recently a meta-analysis showed that Metrodin results in Ͼ50% improvement over HMG in clinical pregnancy rates (1996) reported higher circulating concentrations of FSH with s.c. administration of HP-FSH, but lower circulating oestradiol (Daya, 1995) . This meta-analysis included eight prospective, randomized studies, and seven of them showed that the concentrations and longer duration of stimulation compared to i.m. administration of HMG. The duration of stimulation was pregnancy rates were higher in Metrodin group. In an another recent study including 232 patients it was found that fertilizanotably longer in patients with reduced LH concentrations in the follicular phase. In stimulating oocyte donors, Söderström-tion rate was significantly higher in the Metrodin than in the HMG group (Daya et al., 1995) . Furthermore, a higher Antilla et al. (1996) reported a higher fertilization rate with i.m. HMG compared to s.c. HP-FSH stimulation. However, pregnancy rate was obtained in the Metrodin group, although the difference was found to be insignificant. They concluded the duration of stimulation, number of ampoules used, and clinical pregnancy rates were the same in the two groups. that the advantage of using HMG should be re-evaluated. Similarly, Wikland et al. (1995) in a study including 500 Tomlinson et al. (1996) reported a higher, but not statistically significant, pregnancy rate, in patients stimulated with s.c. HPcouple, found that pregnancy rates were significantly higher in the Metrodin group than in the HMG group (35 versus 18% FSH and undergoing intrauterine insemination (IUI) compared with i.m. HMG stimulated patients. Balasch et al. (1996) per cycle, 40 versus 23% per transfer). Also, fertilization rate
